Coherus Biosciences | CHRS - 销售成本

股票价格
1.82
每天变化
0.03 1.40%
每月一次
8.68%
每年
91.82%
Q2 预测
1.76


金融业
股票价格
USD
资产
USD 258.34M
现金及等价物
USD 88.88M
销售成本
USD 4.05M
流动资产
USD 206.71M
流动负债
USD 140.39M
债务
USD 294.93M
股息收益率
0
EBIT
USD -39.08M
EBITDA
USD -43.33M
员工
306
EPS每股收益
USD -0.43
股本和储备
USD 61.01M
销售毛利
USD 8.7M
债务利息支出
USD 2.25M
贷款资金
USD 51.08M
市值
USD 204.6M
净收入
USD -37.64M
营业费用
USD 51.83M
营业利润
USD -39.08M
普通股股本
USD 121.16M
税前利润
USD -46.35M
销售收入
USD 12.75M
销售和管理费用
USD 15M
股票
USD 3.17M
贸易债权人
USD 9.92M
应收帐款人
USD 18.42M


销售成本 更改 日
AbbVie USD 4.22B 329M 2026-03
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Akebia Therapeutics USD 10.34M 441K 2025-12
ALKERMES USD 73.25M 27.04M 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amarin USD 26.05M 1.41M 2025-12
Amgen USD 1.6B 187M 2026-03
Baxter International USD 1.81B 587M 2026-03
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Coherus Biosciences USD 4.04M 324K 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Fujifilm JPY 509.85B 19.73B 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Merck USD 2.94B 380M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
PTC Therapeutics USD 16.3M 7.02M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Xencor USD 61.66M 50.95M 2025-06
Zoetis USD 743M 60M 2025-12